JPWO2021098757A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021098757A5 JPWO2021098757A5 JP2022524620A JP2022524620A JPWO2021098757A5 JP WO2021098757 A5 JPWO2021098757 A5 JP WO2021098757A5 JP 2022524620 A JP2022524620 A JP 2022524620A JP 2022524620 A JP2022524620 A JP 2022524620A JP WO2021098757 A5 JPWO2021098757 A5 JP WO2021098757A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variable region
- chain variable
- pharmaceutical combination
- combination product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/120033 | 2019-11-21 | ||
| CN2019120033 | 2019-11-21 | ||
| PCT/CN2020/129992 WO2021098757A1 (en) | 2019-11-21 | 2020-11-19 | Methods of cancer treatment using anti-ox40 antibodies in combination with anti-tigit antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502323A JP2023502323A (ja) | 2023-01-24 |
| JP2023502323A5 JP2023502323A5 (https=) | 2023-11-29 |
| JPWO2021098757A5 true JPWO2021098757A5 (https=) | 2023-11-29 |
Family
ID=75980305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022524620A Pending JP2023502323A (ja) | 2019-11-21 | 2020-11-19 | 抗ｔｉｇｉｔ抗体との組合せで抗ｏｘ４０抗体を用いる癌治療の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230002500A1 (https=) |
| EP (1) | EP4061846A4 (https=) |
| JP (1) | JP2023502323A (https=) |
| KR (1) | KR20220103709A (https=) |
| CN (1) | CN114746446A (https=) |
| AU (1) | AU2020385499A1 (https=) |
| BR (1) | BR112022009265A2 (https=) |
| CA (1) | CA3157042A1 (https=) |
| IL (1) | IL293118A (https=) |
| MX (1) | MX2022006148A (https=) |
| WO (1) | WO2021098757A1 (https=) |
| ZA (1) | ZA202204422B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112566935B (zh) | 2018-05-23 | 2024-12-13 | 百济神州有限公司 | 抗ox40抗体和使用方法 |
| TW202216778A (zh) | 2020-07-15 | 2022-05-01 | 美商安進公司 | Ｔｉｇｉｔ及ｃｄ１１２ｒ阻斷 |
| AU2023305697A1 (en) * | 2022-07-15 | 2025-02-20 | Beigene Switzerland Gmbh | Methods of cancer treatment using anti-tigit antibodies |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2494107C2 (ru) * | 2005-05-09 | 2013-09-27 | Оно Фармасьютикал Ко., Лтд. | Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами |
| EP3208612B1 (en) * | 2008-04-09 | 2019-09-18 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| SMT201800503T1 (it) * | 2013-03-18 | 2018-11-09 | Janssen Pharmaceuticals Inc | Anticorpi anti-cd (ox40) umanizzati e loro usi |
| AU2015327868A1 (en) * | 2014-10-03 | 2017-04-20 | Novartis Ag | Combination therapies |
| TW201619200A (zh) * | 2014-10-10 | 2016-06-01 | 麥迪紐有限責任公司 | 人類化抗－ｏｘ４０抗體及其用途 |
| KR20170072343A (ko) * | 2014-11-06 | 2017-06-26 | 제넨테크, 인크. | Ox40 결합 효능제 및 tigit 억제제를 포함하는 병용 요법 |
| TN2019000101A1 (en) * | 2015-05-29 | 2020-07-15 | Bristol Myers Squibb Co | Antibodies against ox40 and uses thereof. |
| GB201519481D0 (en) * | 2015-11-04 | 2015-12-16 | Cancer Rec Tech Ltd | Immunomodulatory antibodies |
| IL272227B2 (en) * | 2017-07-27 | 2025-09-01 | iTeos Belgium SA | Anti-tigit antibodies |
| CN111542544A (zh) * | 2017-11-01 | 2020-08-14 | 百时美施贵宝公司 | 用于治疗癌症的免疫刺激性激动性抗体 |
| KR102769109B1 (ko) * | 2017-11-24 | 2025-02-18 | 유큐(베이징) 바이오파마 코., 엘티디 | 항―ｏｘ４０ 항체 및 그의 용도 |
| TWI816729B (zh) * | 2017-12-30 | 2023-10-01 | 英屬開曼群島商百濟神州有限公司 | 抗tigit抗體及其作為治療和診斷的用途 |
| CN110092832B (zh) * | 2018-01-29 | 2020-03-31 | 康源博创生物科技(北京)有限公司 | 抗ox40抗体及其用途 |
| CN112566935B (zh) * | 2018-05-23 | 2024-12-13 | 百济神州有限公司 | 抗ox40抗体和使用方法 |
-
2020
- 2020-11-19 US US17/778,660 patent/US20230002500A1/en not_active Abandoned
- 2020-11-19 WO PCT/CN2020/129992 patent/WO2021098757A1/en not_active Ceased
- 2020-11-19 IL IL293118A patent/IL293118A/en unknown
- 2020-11-19 CN CN202080080865.7A patent/CN114746446A/zh active Pending
- 2020-11-19 KR KR1020227014833A patent/KR20220103709A/ko active Pending
- 2020-11-19 MX MX2022006148A patent/MX2022006148A/es unknown
- 2020-11-19 EP EP20889442.8A patent/EP4061846A4/en not_active Withdrawn
- 2020-11-19 CA CA3157042A patent/CA3157042A1/en active Pending
- 2020-11-19 AU AU2020385499A patent/AU2020385499A1/en active Pending
- 2020-11-19 JP JP2022524620A patent/JP2023502323A/ja active Pending
- 2020-11-19 BR BR112022009265A patent/BR112022009265A2/pt unknown
-
2022
- 2022-04-20 ZA ZA2022/04422A patent/ZA202204422B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022002520A5 (https=) | ||
| JP2024037894A5 (https=) | ||
| JP2023113893A5 (https=) | ||
| JP2024020298A5 (https=) | ||
| IL318482A (en) | Pd-1 inhibitor for use in a method of treating skin cancer | |
| JP2020528750A5 (https=) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| FI3394103T3 (fi) | Anti-PD-1-vasta-aineiden ja bispesifisten anti-CD20-/anti-CD3-vasta-aineiden yhdistelmä syövän hoitoon | |
| JP2020515247A5 (https=) | ||
| JP2019535254A5 (ja) | 抗ｐｄ−ｌ１抗体および変異型 | |
| JP2021528423A5 (https=) | ||
| CN109843927A (zh) | 抗b7-h3抗体、其抗原结合片段及其医药用途 | |
| JPWO2019246514A5 (https=) | ||
| FI3810281T3 (fi) | Menetelmiä syövän hoitamiseksi bispesifisillä anti-CD3XMUC16-vasta-aineilla ja anti-PD-1-vasta-aineilla | |
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| RU2019104980A (ru) | Анти-icos антитела | |
| RU2018123709A (ru) | Новые антитела для лечения онкологических заболеваний | |
| JPWO2019246356A5 (https=) | ||
| JPWO2020227457A5 (https=) | ||
| CN111246881A (zh) | Pd-1抗体用于治疗肿瘤的用途 | |
| JPWO2021098757A5 (https=) | ||
| JPWO2021098774A5 (https=) | ||
| JPWO2021098758A5 (https=) | ||
| RU2025101095A (ru) | Способы лечения рака с помощью антител против tigit | |
| IL318372A (en) | Methods for treating cancer using antibodies against tigit |